comparemela.com

Latest Breaking News On - Disc replacement - Page 7 : comparemela.com

Las Vegas Resident Travels to Dallas for Back Pain Relief

Las Vegas Resident Travels to Dallas for Back Pain Relief The Center for Disc Replacement is changing lives. By D Partner Studio Published in Sponsored December 17, 2020 1:32 pm In 2019, Ashleigh Tagliaferri, 39, of Las Vegas, Nevada, experienced such intense back pain that it was difficult for her to walk, stand or even sleep. A back surgery four years prior wasn’t proving to be successful. Active all her life and a former gymnast, Tagliaferri had always been a fitness enthusiast with daily runs and group exercise classes. Therefore, she wasn’t accustomed to long bouts of inactivity when severe back pain began to sideline her as a young adult. When sitting became as painful as moving, she knew she had to make a change. While browsing online for back pain solutions, Tagliaferri happened upon a video about artificial disc replacement surgery from the Center for Disc Replacement at Texas Health Center for Diagnostics & Surgery in Dallas. Relief was just over 1,200 miles aw

Simplify Medical Announces First Implantation of its Cervical Artificial Disc in the U S Following 1-Level Approval from the FDA

News Category Global Banking & Finance Reviews Simplify Medical Announces First Implantation of its Cervical Artificial Disc in the U.S. Following 1-Level Approval from the FDA Simplify Medical Announces First Implantation of its Cervical Artificial Disc in the U.S. Following 1-Level Approval from the FDA SUNNYVALE, Calif., Dec. 16, 2020 Simplify Medical, Inc., a privately-held company focused on cervical spinal disc arthroplasty and developer of the Simplify ® Cervical Artificial Disc, today announced its first surgery following the recent FDA approval for 1-level use. The Simplify Disc is designed for MRI compatibility , physiologic motion, and anatomical height-matching, with the goals of improving patient outcomes and expanding treatment options for patients. The Simplify Disc achieved superiority to the fusion control on the trial’s composite primary endpoint (93.0% vs. 73.6%).  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.